Navigation Links
Intensity modulated proton therapy reduces need for feeding tubes by 50 percent
Date:9/25/2013

ATLANTA, GA A new study from researchers at The University of Texas MD Anderson Proton Therapy Center found that the use of feeding tubes in oropharyngeal carcinoma (OPC) cancer patients treated with intensity modulated proton therapy (IMPT) decreased by more than 50 percent compared to patients treated with intensity modulated radiation therapy (IMRT). This suggests that proton therapy may offer vital quality of life benefits for patients with tumors occurring at the back of the throat.

The results, presented today by the lead researcher, Steven J. Frank, M.D., associate professor of Radiation Oncology at MD Anderson at the American Society for Radiation Oncology's 55th Annual Meeting, also indicate that toxicity levels in OPC patients treated with IMPT are much lower than those treated with IMRT.

IMPT, one of the most advanced forms of proton therapy, delivers a precise dose of protons to tumors embedded in the "nooks and crannies" of the head and neck, including the base of tongue and tonsils. MD Anderson treated its first IMPT patient in 2011 and since approximately 150 patients, many with complex head and neck malignancies, have been treated with this form of proton therapy. Unlike IMRT, which destroys both cancerous and healthy cells, IMPT has the ability to destroy cancer cells while sparing surrounding healthy tissue from damage. Therefore, important quality of life outcomes such as neurocognitive function, vision, swallowing, hearing, taste and speech can be preserved in head and neck patients.

"IMPT is especially well-suited for patients with the most complicated tumors of the head and neck, precisely painting the protons onto the tumor layer by layer," said Frank. "In this way, the treatment team can confine the majority of the tumor-damaging energy to target areas and work to protect normal structures such as the oral cavity and brainstem."

OPC cancer develops in the part of the throat just behind the mouth. The American Cancer Society estimates that 36,000 people in the U.S. are diagnosed with cancer of the oral cavity and oropharynx each year (approximately a 20 percent increase since 2010). OPC cancer in most cases is linked to infection with human papilloma virus (HPV) and it's estimated that nearly 70 percent of OPC cancers are HPV-positive.

MD Anderson researchers evaluated 25 OPC patients treated with IMPT and 25 OPC patients treated with IMRT as part of the study. Five patients treated with IMPT required the use of feeding tubes (20 percent) compared to 12 patients treated with IMRT (48 percent). IMPT patients were spared from other serious side effects caused by the toxicity of IMRT such as vomiting, nausea, hearing problems, and mucositis (inflammation and ulceration of the digestive track). In addition, patients could better sustain their nutrition and hydration levels, often leading to faster recovery during and after treatment.

"With a recent epidemic of HPV-associated head and neck cancer among U.S. adults, there is a critical need to minimize the side effects associated with conventional IMRT that affects the patients' courses of treatments, and, ultimately, the rest of their lives," said Frank. "Since radiation therapy is the main tool to treat the disease in this fairly young group of patients, we must understand if more advanced technologies will provide additional value to this patient population."

Based on the results of this study, a Phase II/III randomized trial of IMPT vs. IMRT for the treatment of oropharyngeal cancer of the head and neck is underway at MD Anderson. Over the next five years, MD Anderson aims to enroll 360 patients in the trial, evaluating proton's ability to reduce toxicity across a range of known side effects and enhance long-term cancer survivorship when compared to conformal radiation therapy.


'/>"/>

Contact: Agata Porter
agata.porter@gabbe.com
212-220-4444
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Related medicine news :

1. Intensity Modulated Radiation Therapy optimal for localized prostate cancer
2. Muscular Development Store Releases the Optimum Performance Workout for High Intensity Training
3. Viewing terrorist attacks on TV increases pain intensity -- Ben-Gurion U. researchers
4. Reduced intensity regimen prior to marrow transplant better for older leukemia patients
5. Pain Intensity May Help Differentiate 2 Skin Cancers
6. Smoking intensity and cancer markers predict seriousness of bladder cancer
7. Intensity modulated radiotherapy reduces side effects in patients with early breast cancer
8. Moderate-intensity walking timed just right might help protect against Type 2 diabetes
9. Proton therapy treatment preserves quality of life for men with prostate cancer
10. Horner Flooring to provide court for the MD Anderson Proton Therapy Showcase in Houston.
11. Penn Medicine study: Proton therapy cuts side effects for pediatric head and neck cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , which ... evacuation of the facility as part of a disaster drill on October 3rd. , ... and Shelton City Emergency Manager, as well as the Connecticut Long Term Care ...
(Date:10/13/2017)... NJ (PRWEB) , ... October 13, 2017 , ... Global ... at scenic Alexandria Park in Milford, NJ. This free event, sponsored by Global ... physical activity. The fun run is geared towards children of all ages; it ...
(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... Planet Fitness, ... the U.S., announced today its plans to open a flagship location in Covington, LA ... the former Rooms To Go store next to Office Depot in the Holiday Square ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a ... health care, have expanded their existing home health joint venture through an agreement, ... been operating a joint venture home health company with Asante, delivering clinically integrated ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/22/2017)... SAN DIEGO , Sept. 22, 2017 ... ll medical device is now successfully helping those with ... Union. Fibromyalgia diagnosed Amanda in ... getting dressed and washing my hair, experiencing no sleep ... body in painful spasm… I cannot recommend [the AVACEN ...
Breaking Medicine Technology: